A second Ebola vaccine is to be offered to around 50,000 people in the Democratic Republic of Congo, as part of a major clinical trial. The Johnson & Johnson (J&J) vaccine will be used alongside a vaccine made by Merck, which has already been given to around 250,000 people. Merck’s …
Read More »